Open access
2,068
Views
1
CrossRef citations to date
0
Altmetric
Clinical Measurement
MiToS and King’s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial
Paulos Gebrehiwet1 Cytokinetics, Incorporated, South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-7692-2189View further author information
Lisa Meng1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
, Stacy A. Rudnicki1 Cytokinetics, Incorporated, South San Francisco, CA, USA
https://orcid.org/0000-0002-3499-5208View further author information
Phil Sarocco1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
, Jenny Wei1 Cytokinetics, Incorporated, South San Francisco, CA, USAView further author information
, Andrew A. Wolff1 Cytokinetics, Incorporated, South San Francisco, CA, USA
https://orcid.org/0000-0002-9094-0359View further author information
Adriano Chiò2 Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy
https://orcid.org/0000-0001-9579-5341View further author information
Jinsy A. Andrews3 The Neurological Institute, Columbia University, New York, NY, USA
https://orcid.org/0000-0002-3474-7140View further author information
Angela Genge4 Montreal Neurological Institute, Montreal, QC, Canada
https://orcid.org/0000-0001-5587-9946View further author information
Carlayne E. Jackson5 University of Texas Health Science Center, San Antonio, TX, USA
https://orcid.org/0000-0002-9368-395XView further author information
Noah Lechtzin6 Johns Hopkins School of Medicine, Baltimore, MD, USA
https://orcid.org/0000-0002-9088-8749View further author information
Timothy M. Miller7 Washington University School of Medicine, St. Louis, MO, USA
https://orcid.org/0000-0002-3424-5511View further author information
Jeremy M. Shefner8 Barrow Neurological Institute, Phoenix, AZ, USA
https://orcid.org/0000-0001-5067-5602View further author information
Pages 304-310
|
Received 11 May 2022, Accepted 28 Nov 2022, Published online: 12 Dec 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.